Technetium-99m-MIBI Scintimammography for Suspicious Breast Lesions

Journal of Nuclear Medicine

Volumn 37, Issue 4-6, 1996, Pages 626-630

  Palmedo, Holger ^a   Schomburg, Axel ^a   Grünwald, Frank ^a   Mallmann, Peter ^a   Krebs, Dieter ^a   Biersack, Hans Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Breast cancer; Scintimammography; Technetium 99m MIBI

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADENOCARCINOMA; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOCARCINOMA; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030117316     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kelsey JL, Gammon MD. The epidemiology of breast cancer. Cancer 1991;41: 146-165.
2. Habbema JDF, van Oortmarssen GV, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screen: an analysis of the results of Health Insurance Plan of greater New York study. J Natl Cancer Inst 1986;77:317-320.
3. Hall FM. Screening mammography-potential problems on the horizon. N Engl J Med 1986;314.53-55.
4. Pollei SR, Mettler FA, Bartow SA, Moradian G, Moskowitz M. Occult breast cancer: prevalence and radiographic detectability. Radiology 1987;163:459-462.
5. Hermann G, Janus C, Schwartz IS, Krivisky B, Bier S, Rabinowitz JG. Nonpalpable lesions: accuracy of prebiopsy mammographic diagnosis. Radiology 1987;165:323-326.
6. Kopans DB. Positive predictive value of mammography. AJR 1992;158:521-526.
7. Mann BD, Giuliano AE, Bassett LW, et al. Delayed diagnosis of breast cancer as a result of normal mammograms. Arch Surg 1983;118:23-25.
8. Kalisher L. Factors influencing false negative rates in mammography. Radiology 1979;133:297-301.
9. Kopans DB. Conventional wisdom: observation, experience, anecdote and science in breast imaging. AJR 1994;162:299-303.
10. 201Tl scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993;34:2095-2100.
11. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18-23.
12. 201Tl. Clin Nucl Med 1992;17:171-176.
13. 99mTc-sestamibi imaging: comparison with CT scan. Eur J Nucl Med 1994;21. 973-979
14. Caner B, Kitapci M, Aras T, Erbengi G, Ugur O, Bekdik C. Increased accumulation of sestamibi technetium in osteosarcoma and its metastatic lymph nodes J Nucl Med 1991;32:1977-1978.
15. 99mTc-MIBI in the follow-up of the differentiated thyroid carcinomas. Nuklearmedizin 1991;30;115-124.
16. 99mTc-MIBI in undifferentiated mesenchymal tumor and its metastatic lung lesions. Clin Nucl Med 1992;17:144-145.
17. 201Tl-Cl uptake in primary thyroid lymphoma J Nucl Med 1992;33:1396-1398.
18. 99mTc MDP. J Nucl Med 1992;33: 319-324.
19. Biersack HJ, Briele B, Hotze AL, et al. The role of nuclear medicine in oncology. Ann Nucl Med 1992;6:131-136.
20. 99mTc-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1993;34:1045-1051.
21. 99mTc-sestamibi in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-340.
22. 99mTc-sestamibi. Nuklearmedizin 1994;33:15-23.
23. 201Tl in unsuspected breast tumor. Clin Nucl Med 1992;17:936-937.
24. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m-methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432-436.
25. Khalkhali I, Ismael M, Diggles L Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m-sestamibi. Eur J Nucl Med 1994;21:357-362.
26. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of breast cancer. J Am Coll Surg 1994;178.491-497.
27. 99mTc-MIBI in the evaluation of primary carcinoma of the breast: comparison of palpable and nonpalpable lesions with mammography [Abstract]. J Nucl Med 1994;35:78
28. Lastoria S, Varrella P, Mainolfi C, et al. Technetium-99m-sestamibi scintigraphy in the diagnosis of primary breast cancer [Abstract]. J Nucl Med 1994,35:79.
29. Khalkhali I, Cutrone J, Mena I, et al. Clinical and pathologic follow-up of 100 patients with breast lesions studied with scintimammography [Abstract]. J Nucl Med 1994;35. 80.
30. Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99m-MIBI as an indicator of breast cancer invasiveness. Eur J Nucl Med 1994;21:984-987.
31. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis 2-methoxyisobutylisonitrile technetium in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-1653.